243 results on '"Gheorghe, Liana"'
Search Results
2. Hepatitis B Prevalence and Referral Rates in Vulnerable Populations Undergoing Community-Based Screening—Results from the LIVE(RO)2 Program.
3. Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) – A Prospective Comparative Randomized Trial
4. Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective
5. A portrait of viral hepatitis in the Roma population highlighting potential disparities
6. A New Dawn in Hepatitis D Management.
7. Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure
8. Fatigue Is Associated with Anxiety and Lower Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Remission
9. Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs Therapy
10. Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
11. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
12. The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis
13. Atypical Immunohistochemistry Features in an AFP-producing Colon Cancer
14. Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
15. Do the needle type and the operator experience influence liver biopsy specimen quality?
16. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
17. Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Clinical Remission: What Should We Look For?
18. Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis
19. Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation
20. Reply to “Anticoagulant treatment in cirrhotic portal vein thrombosis –how wide can we open the window?”
21. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience
22. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry
23. Advancing the global public health agenda for NAFLD: a consensus statement
24. Long Term Follow-up of Liver Transplant Recipients: Considerations for Non-transplant Specialists
25. GAVE: a gastroenterologist challenge
26. Normal histology, the new target for ulcerative colitis treatment, might not be the cure
27. Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
28. The Prevalence of HCV Infection and Risk Factors in a Hospital- Based Population Screening, a First Step to the Micro-Elimination of HCV Infection in Medical Institutions from Romania - Results of the HepC ALERT Study
29. Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania
30. Which histopathological and clinical variables are best for predicting the evolution of non-metastased colon cancer
31. Malnutrition Prevalence in Newly Diagnosed Patients with Inflammatory Bowel Disease – Data from the National Romanian Database
32. Tu1545 – Shear Wave Elastography Use for Screening of Clinically Significant Portal Hypertension After Hcv Cure
33. Diagnosis and Treatment of Colonic Diverticular Disease: Position Paper of the Romanian Society of Gastroenterology and Hepatology
34. Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization
35. 100% Sustained Virological Response and Fibrosis Improvement in Real-Life Use of Direct Acting Antivirals in Genotype-1b Recurrent Hepatitis C following Liver Transplantation
36. Early detection of advanced pancreatic cancer after DAA-induced virological cure in a liver transplant recipient with hepatitis C recurrence
37. The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
38. New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania
39. Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two
40. Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis
41. Dynamics of Liver Stiffness Values by means of Transient Elastography in Patients with HCV Liver Cirrhosis undergoing Interferon Free Treatment
42. Position Paper on Treatment of Hepatitis C in Romania, 2017. Part One
43. Alpha Fetoprotein and a Useful Tool for Surveillance of Interferon-Free Treated Cirrhotic Patients for Hepatocellular Carcinoma After SVR
44. Efficacy and Safety of Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir Plus/Minus Ribavirin for Treatment of HCV Genotype 1B Compensated Cirrhosis in Patients Aged 70 Years or Older
45. Assessing mucosal healing in IBD in daily practice
46. Liver Resections in a High-Volume Center: Form Standard Procedures to Extreme Surgery and Ultrasound-guided Resections
47. Curative Intent Treatment of Hepatocellular Carcinoma - 844 Cases Treated in a General Surgery and Liver Transplantation Center
48. The Romanian National Program for Liver Transplantation - 852 Procedures in 815 Patients over 17 Years (2000-2017): A Continuous Evolution to Success
49. A real life boceprevir use in treatment-experienced HCV genotype 1 patients with advanced fibrosis
50. Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.